TNF increases camptothecin-induced apoptosis by inhibition of NF-κB

被引:15
作者
Valente, P
Arzani, D
Cesario, A
Margaritora, S
Carbone, E
Russo, P
机构
[1] Natl Inst Canc Res, Expt Oncol Lab, Mol Pathol Sect, I-16132 Genoa, Italy
[2] Univ Genoa, Genoa, Italy
[3] Univ Cattolica Sacro Cuore, Div Thorac Surg, Dept Surg Sci, Rome, Italy
关键词
apoptosis; camptothecin; TNF; NF-kappa B; DNA elongation; DNA synthesis cell cycle; cytotoxicity; ovarian cancer cells;
D O I
10.1016/S0959-8049(03)00301-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
rHuTNF potentiates CPT-cytotoxicity in human ovarian A2780 cells. In this study, we examined the role of NF-kappaB in this potentiation. A pulse-labelled DNA study indicated that the combination CPT+ TNF had little effect on the rate of DNA elongation at 6 h after drug removal, whereas CPT alone produced a complete inhibition for at least 6 h after drug removal. Flow cytometry analyses showed that CPT + TNF arrested cells in the G(2)-M phase, whereas CPT blocked cells in S phase. Looking at the persistence of the NF-kappaB complexes in cells, it appeared that they were still present at 24 h in TNF-treated cells. In contrast, in CPT-treated cells they persisted for 6 h. In CPT + TNF-treated cells, the NF-kappaB complexes disappeared quickly and became undetectable at 6 h. The induction of apoptosis was detected only in the CPT+ TNF treated cells (using flow cytometry, a filter binding assay and ApopTag staining). These findings show that TNF, in combination with CPT, reduces the time that NF-kappaB complexes persist in cells likely resulting in the induction of apoptosis. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1468 / 1477
页数:10
相关论文
共 27 条
[1]   Control of apoptosis by Rel/NF-κB transcription factors [J].
Barkett, M ;
Gilmore, TD .
ONCOGENE, 1999, 18 (49) :6910-6924
[2]  
BERTRAND R, 1996, DNA DAMAGE, P97
[3]   DNA topoisomerases: Structure, function, and mechanism [J].
Champoux, JJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 :369-413
[4]   GENERALIZED EQUATIONS FOR THE ANALYSIS OF INHIBITIONS OF MICHAELIS-MENTEN AND HIGHER-ORDER KINETIC SYSTEMS WITH 2 OR MORE MUTUALLY EXCLUSIVE AND NON-EXCLUSIVE INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1981, 115 (01) :207-216
[5]  
CHOU TC, 1977, J BIOL CHEM, V252, P6438
[6]  
COVEY JM, 1986, CANCER RES, V46, P5511
[7]  
Cusack JC, 2001, CANCER RES, V61, P3535
[8]  
Debernardis D, 1996, J PHARMACOL EXP THER, V279, P84
[9]  
DelMastro L, 1995, ANTICANCER RES, V15, P2207
[10]  
Elliot P J, 1999, Curr Opin Drug Discov Devel, V2, P484